| abstract |
The invention relates to a method for treating disease such as viral infections, tumors, and cancers, comprising administering a TLR7 agonist or TLR7 agonist prodrug according to a cyclical dosing schedule having a dosing period and a resting period. For example, the mmethod encompasses treating disease with: Formula (I) 5-amino-3-(2 '-Q-aceiyl-3'-deoxy-β-D-ribofuranosyl)-3H-thiazolo[4,5-d]pyrimidin-2-one Tosylate according to a dosing schedule of every -other-day or a dosing schedule of three consecutive days of dosing followed by four consecutive days of not dosing. |